Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of EarningsStock Story·12 hours agoINCY-4.00%NTRA+0.66%
12:37 ETREGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuitprnewswire·22 hours agoREGN+1.47%
Fujian Haixi Pharma wins FDA IND clearance for HX9428 Phase II nAMD trialPUBT·1 day ago, 04:13 AM02637+7.25%REGN+1.47%
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $740.00 Price Target at CitigroupMarket Beat·1 day ago, 02:12 PMREGN+1.47%
6 Health Care Stocks Whale Activity In Today’s Sessionbenzinga_article·1 day ago, 12:35 PMUNH+0.89%NVO+1.92%
04:43 ETRegeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - REGNprnewswire·2 days ago, 03:43 AMREGN+1.47%
How Investors May Respond To Telix Pharmaceuticals (ASX:TLX) Upgraded FY26 Guidance And Pipeline MilestonesSimplywall·Aug 2 at 06:12 AMTLX+1.51%REGN+1.47%
Regeneron (REGN) Stock Price Faces Margin Squeeze Despite 17% Revenue GrowthSimplywall·Aug 1 at 02:24 AMREGN+1.47%
Regeneron Pharmaceuticals, Inc. (REGN) Faces Securities Class Action Amid Disclosures About Key Trial's Protocol and Ultimate Failure - HBSSPR Newswire·Jul 31 at 01:32 PMREGN+1.47%
